ghk-cu receptor binding mechanism 50mg GHK-Cu (Copper Peptide) Deep Dive:

Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity

This age-related decline has made it a subject of considerable interest in longevity and tissue repair research

Evidence across these actives is strongest in preclinical and early translational settings (for GHK-Cu, human cosmetic/dermatologic data also exist)

Malabsorption Disorders: Conditions such as pernicious anemia, Crohns disease, celiac disease, or a history of gastric bypass surgery can hinder B12 absorption

It's biochemically inert